| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Chester Beatty Research Institute, Institute of Cancer Research: Royal Cancer Hospital, London
To assess future possibilities of treatments of leukemia, biochemical and biologic characterizations of the disease under discussion have been reviewed. These characterizations have been used as base lines for speculations and have been summarized in Table 1. A distinction has been made between drugs that destroy leukemic cells and homeostatic regulators that might achieve palliation or cure by redressing imbalances in the leukopoietic systems.
1 This work has been supported by grants to the Chester Beatty Research Institute (Institute of Cancer Research: Royal Cancer Hospital) from the British Empire Cancer Campaign, the Medical Research Council, and the National Cancer Institute, NIH, USPHS.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |